Sara Tolaney, MD, Associate Director, Susan F. Smith Center for Womens Cancers, Director Clinical Trials, Breast Oncology, Associate Professor of Medicine, Harvard Medical School discusses the outcomes from the MONALEESA-7 trial in premenopausal metastatic breast cancer.
premenopausal metastatic breast cancer, monaleesa-7 trial, outcomes
Advertisement